Leidos Beats Q1 Aided By Government Technology Market; Reiterates FY22 Guidance

Comments
Loading...
  • Leidos Holdings, Inc LDOS reported first-quarter FY22 revenue growth of 5% year-on-year to $3.49 billion, beating the consensus of $3.38 billion. Revenue grew 4% organically.
  • The most significant revenue contributors were the start-up of the Navy Next Generation Enterprise Network Recompete (NGEN-R) Service Management, Integration and Transport (SMIT) contract and the increased deployments on the Defense Healthcare Management System Modernization (DHMSM) program.
  • Defense Solutions' revenue rose 5% Y/Y to $2.05 billion. Civil revenue grew 4% to $795 million. Health revenue expanded 10% Y/Y to $650 million.
  • Net bookings totaled $5.4 billion, representing a book-to-bill ratio of 1.6. As a result, the backlog was $36.3 billion. 
  • The adjusted EBITDA margin contracted by 150 bps to 10.2%.
  • Non-GAAP EPS of $1.58 beat the consensus of $1.50.
  • Leidos held $297 million in cash and equivalents and generated $93 million in operating cash flow.
  • Chair and CEO Roger Krone commented, "Our first quarter marked a strong start to 2022, with record levels of revenues and backlog stemming from our leadership position in the government technology market."
  • Dividend: The board declared a cash dividend of $0.36 per share, payable on June 30, 2022, to stockholders of record on June 15, 2022.
  • Outlook: Leidos reiterated FY22 revenue guidance of $13.9 billion - $14.3 billion, versus the consensus of $14.1 billion.
  • Leidos sees non-GAAP EPS of $6.10 - $6.50 versus the consensus of $6.50.
  • Price Action: LDOS shares traded lower by 0.56% at $102.93 on the last check Tuesday.
Overview Rating:
Good
62.5%
Technicals Analysis
66
0100
Financials Analysis
60
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!